TP82. TP082 LET IT BE - CLINICAL ADVANCES IN PULMONARY VASCULAR DISEASE: PAH AND BEYOND最新文献

筛选
英文 中文
Prevalence of Pulmonary Hypertension in Relation to Obesity: A National Inpatient Sample Analysis 肺动脉高压患病率与肥胖的关系:一项全国住院患者样本分析
TP82. TP082 LET IT BE - CLINICAL ADVANCES IN PULMONARY VASCULAR DISEASE: PAH AND BEYOND Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3598
M. Ramirez, R. Atluri, P. R. Rodriguez Alarcon, K. Bustos, M. Murthi
{"title":"Prevalence of Pulmonary Hypertension in Relation to Obesity: A National Inpatient Sample Analysis","authors":"M. Ramirez, R. Atluri, P. R. Rodriguez Alarcon, K. Bustos, M. Murthi","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3598","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3598","url":null,"abstract":"","PeriodicalId":439802,"journal":{"name":"TP82. TP082 LET IT BE - CLINICAL ADVANCES IN PULMONARY VASCULAR DISEASE: PAH AND BEYOND","volume":"150 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122766653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Pharmacokinetic/Pharmacodynamic Based Rationale for Dose Selection of the TPH Inhibitor Rodatristat Ethyl in ELEVATE-2 - a Phase 2b Study in Pulmonary Arterial Hypertension 基于药代动力学/药效学的TPH抑制剂Rodatristat Ethyl在ELEVATE-2治疗肺动脉高压的2b期研究中剂量选择的基本原理
TP82. TP082 LET IT BE - CLINICAL ADVANCES IN PULMONARY VASCULAR DISEASE: PAH AND BEYOND Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3604
B. Johnson, M. Palacios, J. Zhou, V. Schmith, S. Wring
{"title":"A Pharmacokinetic/Pharmacodynamic Based Rationale for Dose Selection of the TPH Inhibitor Rodatristat Ethyl in ELEVATE-2 - a Phase 2b Study in Pulmonary Arterial Hypertension","authors":"B. Johnson, M. Palacios, J. Zhou, V. Schmith, S. Wring","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3604","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3604","url":null,"abstract":"","PeriodicalId":439802,"journal":{"name":"TP82. TP082 LET IT BE - CLINICAL ADVANCES IN PULMONARY VASCULAR DISEASE: PAH AND BEYOND","volume":"4 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125009443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Baseline Assessment and Follow Up of Veterans with Groups 2 and 3 Pulmonary Hypertension Treated with Vasodilator Therapy: A Qualitative Study 血管扩张剂治疗2组和3组退伍军人肺动脉高压的基线评估和随访:一项定性研究
TP82. TP082 LET IT BE - CLINICAL ADVANCES IN PULMONARY VASCULAR DISEASE: PAH AND BEYOND Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3616
K. R. Gillmeyer, S. Johnson, R. Bolton, M. McCullough, R. Wiener
{"title":"Baseline Assessment and Follow Up of Veterans with Groups 2 and 3 Pulmonary Hypertension Treated with Vasodilator Therapy: A Qualitative Study","authors":"K. R. Gillmeyer, S. Johnson, R. Bolton, M. McCullough, R. Wiener","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3616","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3616","url":null,"abstract":"","PeriodicalId":439802,"journal":{"name":"TP82. TP082 LET IT BE - CLINICAL ADVANCES IN PULMONARY VASCULAR DISEASE: PAH AND BEYOND","volume":"34 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131455884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Selexipag Titration and Dosing Patterns in Patients with Pulmonary Arterial Hypertension (PAH) in a Real-World Clinical Setting: Insights from the EXPOSURE Study 真实世界临床环境中肺动脉高压(PAH)患者的Selexipag滴定和给药模式:来自暴露研究的见解
TP82. TP082 LET IT BE - CLINICAL ADVANCES IN PULMONARY VASCULAR DISEASE: PAH AND BEYOND Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3607
T. Lange, S. Söderberg, P. Biedermann, A. Muller, K. Luik, P. Escribano, S. Gaine
{"title":"Selexipag Titration and Dosing Patterns in Patients with Pulmonary Arterial Hypertension (PAH) in a Real-World Clinical Setting: Insights from the EXPOSURE Study","authors":"T. Lange, S. Söderberg, P. Biedermann, A. Muller, K. Luik, P. Escribano, S. Gaine","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3607","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3607","url":null,"abstract":"","PeriodicalId":439802,"journal":{"name":"TP82. TP082 LET IT BE - CLINICAL ADVANCES IN PULMONARY VASCULAR DISEASE: PAH AND BEYOND","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122316823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Comparison of Sleep Apnea Severity in World Health Organization Pulmonary Hypertension Groups 世界卫生组织肺动脉高压组睡眠呼吸暂停严重程度的比较
TP82. TP082 LET IT BE - CLINICAL ADVANCES IN PULMONARY VASCULAR DISEASE: PAH AND BEYOND Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3578
J. Simonson, D. Pandya, S. Verma, H. Greenberg, A. Talwar
{"title":"Comparison of Sleep Apnea Severity in World Health Organization Pulmonary Hypertension Groups","authors":"J. Simonson, D. Pandya, S. Verma, H. Greenberg, A. Talwar","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3578","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3578","url":null,"abstract":"","PeriodicalId":439802,"journal":{"name":"TP82. TP082 LET IT BE - CLINICAL ADVANCES IN PULMONARY VASCULAR DISEASE: PAH AND BEYOND","volume":"5 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131123690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Phase 1b, Multi-Center, Randomized, Placebo-Controlled Trial of Inhaled Seralutinib in Subjects with WHO Group 1 Pulmonary Arterial Hypertension 吸入塞拉鲁替尼治疗WHO 1组肺动脉高压的1b期多中心随机安慰剂对照试验
TP82. TP082 LET IT BE - CLINICAL ADVANCES IN PULMONARY VASCULAR DISEASE: PAH AND BEYOND Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3602
R. Frantz, K. Highland, J. McConnell, C. Burger, R. Roscigno, M. Cravets, R. McCaffrey, L. Zisman, L. Howard
{"title":"A Phase 1b, Multi-Center, Randomized, Placebo-Controlled Trial of Inhaled Seralutinib in Subjects with WHO Group 1 Pulmonary Arterial Hypertension","authors":"R. Frantz, K. Highland, J. McConnell, C. Burger, R. Roscigno, M. Cravets, R. McCaffrey, L. Zisman, L. Howard","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3602","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3602","url":null,"abstract":"","PeriodicalId":439802,"journal":{"name":"TP82. TP082 LET IT BE - CLINICAL ADVANCES IN PULMONARY VASCULAR DISEASE: PAH AND BEYOND","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130527143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Development and Testing of Walk Talk Track App - A Wearables-Based Platform for Mobile 6MWT Monitoring 基于可穿戴设备的移动6MWT监控平台Walk - Talk Track App的开发与测试
TP82. TP082 LET IT BE - CLINICAL ADVANCES IN PULMONARY VASCULAR DISEASE: PAH AND BEYOND Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3611
V. Glinskii, R.J. Anderson, A. Lopez, A. Lin, P. Del Rosario, S. Hershman, J. Hess, V. De Jesus Perez, R. Zamanian
{"title":"Development and Testing of Walk Talk Track App - A Wearables-Based Platform for Mobile 6MWT Monitoring","authors":"V. Glinskii, R.J. Anderson, A. Lopez, A. Lin, P. Del Rosario, S. Hershman, J. Hess, V. De Jesus Perez, R. Zamanian","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3611","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3611","url":null,"abstract":"","PeriodicalId":439802,"journal":{"name":"TP82. TP082 LET IT BE - CLINICAL ADVANCES IN PULMONARY VASCULAR DISEASE: PAH AND BEYOND","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127646467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pulmonary Blood Volume in Older Adults Assessed by Dual-Energy Computed Tomography: The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study 双能计算机断层扫描评估老年人肺血容量:动脉粥样硬化(MESA)肺研究的多民族研究
TP82. TP082 LET IT BE - CLINICAL ADVANCES IN PULMONARY VASCULAR DISEASE: PAH AND BEYOND Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3580
E. Hermann, G. Hiura, E. Hoffman, A. Motahari, S. Gerard, P. Nagpal, A. Eskandari, J. Go, N. Allen, A. Bertoni, D. Bluemke, J. Pankow, E. Michos, K. Hinckley Stukovsky, David W. Kaczka, K. Watson, R. Barr
{"title":"Pulmonary Blood Volume in Older Adults Assessed by Dual-Energy Computed Tomography: The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study","authors":"E. Hermann, G. Hiura, E. Hoffman, A. Motahari, S. Gerard, P. Nagpal, A. Eskandari, J. Go, N. Allen, A. Bertoni, D. Bluemke, J. Pankow, E. Michos, K. Hinckley Stukovsky, David W. Kaczka, K. Watson, R. Barr","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3580","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3580","url":null,"abstract":"Rationale The pulmonary vasculature is critical for gas exchange, impacts both pulmonary and cardiac function, and has renewed importance due to COVID-19. Pulmonary blood volume is, however, technically difficult to assess, generally requiring invasive methodology for quantification. Prior studies are limited in size and participant enrollment was selective;therefore, variation in the general population is largely unknown. We performed contrast-enhanced dual-energy computed tomography (DECT) in a multicenter, community-based cohort to describe variation in pulmonary perfused blood volume (PBV) in the community. MethodsThe Multi-Ethnic Study of Atherosclerosis (MESA) recruited adults from six sites. The MESA Lung Study invited all MESA participants attending Exam 6 (2017-18), excluding those with kidney disease and contrast allergy, to undergo DECT at functional residual capacity via Siemens Flash or Force scanner: CareDose on, pitch 0.55, 0.25 sec exposure, 0.5mm slice thickness, iterative reconstruction (Admire) with Qr40 Kernel. Half concentration 370mg/ml Iopamidol was delivered at 4ml/s for the full scan, starting 17 seconds prior to scanning, including a ∼4 sec breath hold. PBV was calculated by material decomposition and normalized with iodine concentration in the pulmonary trunk. Generalized linear regression models included age, sex, race/ethnicity, height, weight, smoking status, site, and education.ResultsDECT scans were acquired for 714 participants, 36 of which were excluded due to image quality. Mean age of the remaining 678 participants was 71 years (range 63 - 79), 55% were male, 51% were ever smokers, and the race/ethnic distribution was 41% White, 29% Black, 17% Hispanic, and 13% Asian. Mean PBV was 468 + 151mL. The strongest demographic correlate was lower PBV with greater age (-30 mL per 10 years, 95% CI: -43, -18, p<0.001). Pulmonary PBV was positively associated with height, weight, and male sex (all P<0.001). PBV was lower in former compared to never smokers (p =0.04) and in Black than White participants (p=0.002), but not in Hispanic or Asian participants. There were no consistent differences across education or study site. Results were similar after adjustment for lung function and percent emphysema on CT.ConclusionsTo our knowledge, this is the first assessment of pulmonary PBV in a large, multiethnic, general community sample. Pulmonary PBV assessed by contrast-enhanced DECT was substantially reduced with advancing age and varied with body size, sex, former smoking, and, to a lesser extent, Black race. Understanding variation in pulmonary PBV in the general population may elucidate risk of cardiopulmonary disease and physical function.","PeriodicalId":439802,"journal":{"name":"TP82. TP082 LET IT BE - CLINICAL ADVANCES IN PULMONARY VASCULAR DISEASE: PAH AND BEYOND","volume":"44 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115630752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Estimated vs Measured PaCO2 in Heart Failure Patients with Preserved Ejection Fraction 保留射血分数的心力衰竭患者的PaCO2估计值与测量值
TP82. TP082 LET IT BE - CLINICAL ADVANCES IN PULMONARY VASCULAR DISEASE: PAH AND BEYOND Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3587
B. Balmain, R. Moran, S. Livingston, M. Morris, C. Foulk, M. Payne, M. Samels, J. MacNamara, S. Sarma, A. Tomlinson, B. Levine, T. Babb
{"title":"Estimated vs Measured PaCO2 in Heart Failure Patients with Preserved Ejection Fraction","authors":"B. Balmain, R. Moran, S. Livingston, M. Morris, C. Foulk, M. Payne, M. Samels, J. MacNamara, S. Sarma, A. Tomlinson, B. Levine, T. Babb","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3587","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3587","url":null,"abstract":"","PeriodicalId":439802,"journal":{"name":"TP82. TP082 LET IT BE - CLINICAL ADVANCES IN PULMONARY VASCULAR DISEASE: PAH AND BEYOND","volume":"51 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122811454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationships Between Body Mass Index and Survival in Patients with Chronic Lung Disease Associated Pulmonary Hypertension 慢性肺部疾病相关肺动脉高压患者体重指数与生存的关系
TP82. TP082 LET IT BE - CLINICAL ADVANCES IN PULMONARY VASCULAR DISEASE: PAH AND BEYOND Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3577
T. Qiu, D. Huang, Y. Zhang, S. Gong, L. Wang, R. Zhang
{"title":"Relationships Between Body Mass Index and Survival in Patients with Chronic Lung Disease Associated Pulmonary Hypertension","authors":"T. Qiu, D. Huang, Y. Zhang, S. Gong, L. Wang, R. Zhang","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3577","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3577","url":null,"abstract":"","PeriodicalId":439802,"journal":{"name":"TP82. TP082 LET IT BE - CLINICAL ADVANCES IN PULMONARY VASCULAR DISEASE: PAH AND BEYOND","volume":"31 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121633320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书